Is prospective MRI mapping of the changes in the volume of the prostate gland in prostate cancer patients undergoing 6 months of neo‐adjuvant androgen deprivation therapy a step towards a trial to determine those who may benefit from treatment intensification or extended duration?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is prospective MRI mapping of the changes in the volume of the prostate gland in prostate cancer patients undergoing 6 months of neo‐adjuvant androgen deprivation therapy a step towards a trial to determine those who may benefit from treatment intensification or extended duration?

Published:2020-03-15 Issue:2 Volume:64 Page:287-292
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:J Med Imaging Radiat Oncol

Author:

Christie David RH¹²^ORCID,Sharpley Christopher F²,Mitina Natalia¹³,MacAteer Eamonn⁴,Jackson James E⁵⁶,Lunn Dominic⁵

Affiliation:

1. GenesisCare Tugun Queensland Australia

2. Brain‐Behaviour Research Group University of New England Armidale New South Wales Australia

3. University of Queensland St Lucia Queensland Australia

4. South Coast Radiology Pindara Hospital Benowa Queensland Australia

5. Icon Cancer Centre Gold Coast University Hospital Southport Queensland Australia

6. School of Medicine Griffith University Gold Coast Queensland Australia

Funder

Ipsen Fund

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1754-9485.13017

Reference19 articles.

1. Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression

2. Neoadjuvant androgen deprivation for prostate volume reduction: The optimal duration in prostate cancer radiotherapy

3. Fate of Seminal Vesicles and Prostate After Medical Castration: How Long Is the Optimal Duration of Neoadjuvant Treatment for Prostate Cancer Before Radiation?

4. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

5. Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term oncological outcomes after multimodal treatment for locally advanced prostate cancer;BJUI Compass;2024-08

2. Predictive Value of Preoperative PSA Levels Combined with MRI Features for BCR after Radical Prostatectomy: A Retrospective Study;Archivos Españoles de Urología;2024

3. The clinical guiding value of a radiomics model for androgen deprivation therapy for prostate cancer;Journal of International Medical Research;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3